BenchSci raises $70 million to accelerate drug discovery using artificial intelligence

BenchSci raises $70 million to accelerate drug discovery using artificial intelligence

by

Toronto artificial intelligence startup BenchSci has raised C$95 million, or $70 million, in funding to help scientists discover new drugs faster. BenchSci, officially Scinapsis Analytics Inc., announced Series D round on Thursday. It detailed that Generation Investment Management was the lead investor. Returning backers iNovia Capital, TCV, Golden Ventures and F-Prime Capital also participated, bringing … Read more